The Celltrion Group

Celltrion Group is a South Korean biopharmaceutical company specializing in developing and manufacturing innovative medicines, particularly biosimilars—cost-effective versions of existing biologic drugs. They focus on treating diseases like cancer, rheumatoid arthritis, and COVID-19. With advanced technology and global collaborations, Celltrion aims to make high-quality healthcare more accessible worldwide. Their operations include research, development, manufacturing, and distribution of these medicines, positioning them as a key player in the biotech industry. Overall, they work to improve patient outcomes through affordable, effective biological therapies.